Financings in Brief: Beckman Instruments
This article was originally published in The Gray Sheet
Beckman Instruments: Issues $100 mil. in debentures due June 1, 2026 at an interest rate of 7.05%. Proceeds will be used to fund "general corporate purposes and to repay the company's existing commercial paper borrowings," Beckman says. Beckman filed a registration statement with the Securities and Exchange Commission in April for issuance of up to $200 mil. in debt securities. The company says it "currently has no plans to issue the remaining $100 mil." covered by the SEC filing...
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.